 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
1 to 10 of 10 results |
|
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
Ashford J. on PAPER: Phelan EA. et al., 2012, The data presented in this paper provide strong evidence that doctors need to be aware of a... 25 Jan 2012.
|
 |
 |
 |
 |
 |
Ashford J. on PAPER: De Meyer G. et al., 2010, The Stanford Neurology Department held a journal club meeting on this paper, conducted by... 9 Sep 2010.
|
 |
 |
 |
 |
 |
Ashford J. on PAPER: Laxton AW. et al., 2010, I have studied Alzheimer disease (AD) since 1978, and since about 1980, I have seen some new... 13 Aug 2010.
|
 |
 |
 |
 |
 |
Ashford J, Casadesus G, Greco S, Johnston J, Perry G, Smith M, Tezapsidis N. on PAPER: Lieb W. et al., 2009, Comment by Mark A. Smith, Steven Greco, Jane M. Johnston, J. Wesson Ashford, George Perry,... 13 Jan 2010.
|
 |
 |
 |
 |
 |
Ashford J. on LIVE DISCUSSION: Can We (Should We?) Develop “Smart Drugs” to Stave Off Age-Related Memory Loss?, I have two comments that I still feel need to be clarified with respect to Dr. Small's... 13 Mar 2009.
|
 |
 |
 |
 |
 |
Ashford J. on LIVE DISCUSSION: Can We (Should We?) Develop “Smart Drugs” to Stave Off Age-Related Memory Loss?, 1. I believe there is no evidence that any Alzheimer medication helps individuals without... 26 Feb 2009.
|
 |
 |
 |
 |
 |
Ashford J. on NEWS: Antipsychotics on Trial Again—DART-AD Confirms Increased Mortality, Alzheimer patients can be extremely difficult to treat. They can be very dangerous to the... 9 Jan 2009.
|
 |
 |
 |
 |
 |
Ashford J. on PAPER: Palop JJ. et al., 2007, This is an interesting paper coming from an excellent research group.
I agree that neural... 11 Sep 2007.
|
 |
 |
 |
 |
 |
Ashford J. on PAPER: Zha XM. et al., 2006, I think that this study is very interesting and well carried out. To some extent, this is an... 31 Oct 2006.
|
 |
 |
 |
 |
 |
Ashford J. on PAPER: Collins MO. et al., 2005, With reference to Alzheimer disease and memory mechanisms, this paper identifies 600... 16 Dec 2004.
|
 |
 |
 |
 |
 |
 |
1 to 10 of 10 results |
|
 |
|
 |
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 The ALS Forum is a web-based collaborative effort to bring together valuable ALS-related resources for use by researchers worldwide in both academia and industry-based settings.
|
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
Should the FDA be allowed to use data from overseas clinical trials? |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
Absolutely, we are running out of viable subjects in the U.S. |
 |
 |
 |
 |
 |
 |
9 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
Yes, so long as the data is reliable |
 |
 |
 |
 |
 |
 |
31 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
No, the trials are not as rigorous |
 |
 |
 |
 |
 |
 |
3 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
No, the data should be repeated in the U.S. |
 |
 |
 |
 |
 |
 |
5 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
No, the drug sponsors are just trying to cut corners |
 |
 |
 |
 |
 |
 |
3 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
Responses: 51 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
|
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
Archived Polls |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |

|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
 |